Corrigendum to "Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials"
Cephalalgia
.
2024 Jun;44(6):3331024241255216.
doi: 10.1177/03331024241255216.
PMID:
38934595
DOI:
10.1177/03331024241255216
No abstract available
Publication types
Published Erratum